Top

Osteoporosis International

Published in:

01-06-2006 | Original Article

Outcomes of a disease-management program for patients with recent osteoporotic fracture

Authors: M. Che, B. Ettinger, J. Liang, A. R. Pressman, J. Johnston

Published in: Osteoporosis International | Issue 6/2006

Abstract

Introduction

The purpose of this study was to evaluate outcomes of a disease-management program designed to increase rates of bone-mineral-density (BMD) testing and initiation of osteoporosis medication among patients with a recent osteoporotic fracture.

Study design

We identified 744 consecutive patients aged ≥55 years who were seen at either of 2 of 14 Kaiser Permanente medical facilities in Northern California (KPNC) after sustaining a fracture of the hip, spine, wrist, or humerus between April 2003 and May 2004. These patients were invited to participate in a study of the Fragile Fracture Management Program, whose protocol used fracture-risk assessment tools to determine treatment recommendations. Postfracture care of study participants was compared with usual postfracture care received by osteoporotic-fracture patients at 12 other KPNC facilities.

Results

Of the 744 patients who were invited to participate in the study, 293 (39%) agreed to participate, and 169 (23%) completed the evaluation. Of these 169 patients (127 women, 42 men), 65 (51%) of the women and 7 (17%) of the men qualified for drug treatment; of these 72 patients, 6 (86%) of the men and 41 (63%) of the women accepted the offered treatment. At the two study locations, rates of care (BMD testing or prescribing osteoporosis medication) were about twice as high as rates of usual postfracture care observed at 12 other medical centers in KPNC.

Conclusions

Compared with patients who received usual care for osteoporotic fracture, patients participating in a postfracture disease management program had substantially higher rates of medical attention given for osteoporosis; however, the overall yield of the program was low. This low uptake rate was related to factors not previously appreciated: many patients refused participation in the program; a high proportion of younger women—and men of all ages—did not qualify for treatment; and treatment was refused by one in three study-qualified women and by one in seven study-qualified men. Additional efforts are needed to overcome patient barriers to improved osteoporosis evaluation, treatment and participation in postfracture programs.

Available only for authorised users

Klotzenbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15(4):721–739CrossRef

Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320–323PubMedCrossRef

Ross PD, Davis JW, Epstein RS, Wasnich RD (1991) Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114(11):919–923PubMed

Hajcsar EE, Hawker G, Bogoch ER (2000) Investigation and treatment of osteoporosis in patients with fragility fractures. CMAJ 163(7):819–822PubMed

Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA (2000) Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am 82-A(8):1063–1070PubMed

National Committee for Quality Assurance (2004) The state of health care quality: 2004. Washington (DC): National Committee for Quality Assurance. http://www.ncqa.org/communications/SOMC/SOHC2004.pdf. Cited 2005 Mar 28

Gault MH, Longerich LL, Harnett JD, Wesolowski C (1992) Predicting glomerular function from adjusted serum creatinine [editorial]. Nephron 62(3):249–256PubMedCrossRef

National Osteoporosis Foundation. Physician’s guide to prevention and treatment of osteoporosis. Washington (DC): National Osteoporosis Foundation (1999) Available from: http://www.nof.org/_vti_bin/shtml.dll/physguide/index.htm. Cited 2005 Mar 28

Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS et al (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12(7):519–528PubMedCrossRef

10.

Ettinger B, Hiller TA, Pressman A, Che M, Hanley DA (2005) Simple computer model for calculating and reporting 5-year osteoporotic fracture risk in postmenopausal women. J Womens Health (Larchmt) 14(2):159–171

11.

Siris ES, Bilezikian JP, Rubin MR, Black DM, Bockman RS, Bone HG et al (2003) Pins and plaster aren’t enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab 88(8):3482–3426CrossRef

12.

Cuddihy MT, Amadio PC, Gabriel SE, Pankratz VS, Kurland RL, Melton LJ III (2004) A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture. Osteoporos Int 15(9):695–700PubMedCrossRef

13.

Hawker G, Ridout R, Ricupero M, Jaglal S, Bogoch E (2003) The impact of a simple fracture clinic intervention in improving the diagnosis and treatment of osteoporosis in fragility fracture patients. Osteoporos Int 14(2):171–178PubMed

14.

Simonelli C, Killeen K, Mehle S, Swanson L (2002) Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc 77(4):334–338PubMed

15.

Centers for Medicare & Medicaid Services (2005) Medicare “Pay for Performance (P4P)” initiatives. http://www.cms.hhs.gov/media/press/release.asp?Counter=1343. Cited 2005 Mar 28

16.

Newman ED, Ayoub WT, Starkey RH, Diehl JM, Wood GC (2003) Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years. Osteoporos Int 14(2):146–151PubMed

17.

NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785–795CrossRef

18.

Kanis JA, Johnell O, Oden A, Borgstrom F, Johansson H, De Laet C et al (2005) Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int 16(1):6–14PubMedCrossRef

19.

Sidwell AI, Wilkinson TJ, Hanger HC (2004) Secondary prevention of fractures in older people: evaluation of a protocol for the investigation and treatment of osteoporosis. Intern Med J 34(3):129–132PubMedCrossRef

20.

Newman ED (2003) A schema for effective osteoporosis management: outcomes of the Geisinger Health System Osteoporosis Program. Dis Manage Health Outcomes 11(10):611–616CrossRef

21.

Snyder JW, Malaskovitz J, Griego J, Persson J, Flatt K (2003) Quality improvement and cost reduction realized by a purchaser through diabetes disease management. Dis Manag 6(4):233–241PubMedCrossRef

22.

Boulet LP, Thivierge RL, Amesse A, Nunes F, Francoeur S, Collet JP (2002) Towards excellence in asthma management (TEAM): a populational disease-management model. J Asthma 39(4):341–350PubMedCrossRef

23.

McClung M (2004) Bone density by itself does not accurately predict fracture risk (NORA data) [commentary on two articles]. Menopause Management 13(5):37–39

Title: Outcomes of a disease-management program for patients with recent osteoporotic fracture
Authors: M. Che
B. Ettinger
J. Liang
A. R. Pressman
J. Johnston
Publication date: 01-06-2006
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 6/2006
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-005-0057-y

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Outcomes of a disease-management program for patients with recent osteoporotic fracture

Abstract

Introduction

Study design

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction

Study design

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2006

Treatment of osteoporosis with TheraCyte-encapsulated parathyroid cells: a study in a rat model

Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture

Determinants of adherence to osteoporosis treatment in clinical practice

Persistence with weekly alendronate therapy among postmenopausal women

Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation

ALDH2 polymorphisms and bone mineral density in an elderly Japanese population